Announcement PDF 21 October 2024 Dear Shareholder, Annual General Meeting – Notice of Meeting and Proxy Form On behalf of the Board of Directors of Cryosite Limited (ASX:CTE) (“Cryosite” or the “Company), I am pleased to invite you to Cryosite’s 2024 Annual General Meeting (AGM). The AGM will be held at 11:00am (AEDT) on Friday, 22 November 2024 at Boardroom, Level 2 90 William St, Melbourne, VIC, 3000. The Notice of the AGM, which contains important information about the matters to be considered at the AGM, is being made available to Shareholders electronically can be found at Cryosite’s ASX market announcements page: https://www.asx.com.au/markets/company/CTE In accordance with Part 1.2AA of the Corporations Act 2001, a physical copy of the Notice of Meeting will only be mailed to Shareholders who have elected to receive a hard copy of meeting documents. If you wish to amend your shareholder communication election to receive a hard copy of the Notice of AGM, please contact Cryosite’s share registry, Link Market Services, on +61 1300 554 474. Shareholders who are unable to attend the AGM are encouraged to lodge a proxy prior to the meeting. To do so, Shareholders should follow the instructions on their personalised proxy form enclosed to this letter. Proxies must be lodged by no later than 11.00am (AEDT) on Wednesday, 20 November 2024. Thank you for your continued support of Cryosite and I look forward to your attendance at the AGM. By Order of the Board of Directors Yours faithfully Mark Kerr Chairman Cryosite Ltd | 13a Ferndell Street, South Granville NSW 2142| t: +61 (2) 8865 2000 | e: corporate@cryosite.com | www.cryosite.com CRYOSITE LIMITED ACN 090 919 476 NOTICE OF ANNUAL GENERAL MEETING Notice is given that the Annual General Meeting (AGM or Meeting) of Shareholders of Cryosite Limited (Cryosite or the Company) will be held: Date: Friday, 22 November 2024 Time: 11.00am (Melbourne time) Venue: Boardroom, Level 2 90 William St, Melbourne, VIC, 3000 The Explanatory Memorandum accompanying this Notice of Meeting provides additional information on matters to be considered at the AGM. The Explanatory Memorandum, The Entitlement to Attend and Vote Section and the Proxy Form are part of this Notice of Meeting. The business of the Meeting is as follows: A CONSIDERATION OF REPORTS To receive and consider the Company’s Financial Report, the Directors' Report and the Independent Auditor's Report for the financial year ended 30 June 2024. All Shareholders can view the Annual Report which contains the Annual Financial Report, the Directors’ Report and the Independent Auditor’s Report for the year ended 30 June 2024 on the Company’s ASX page at: https://www.asx.com.au/markets/company/CTE B. QUESTIONS AND COMMENTS Following consideration of the Reports, the Chairman will give Shareholders attending the Meeting a reasonable opportunity to ask questions about, or comment on, the Reports and the management of the Company. The Chairman will also give Shareholders a reasonable opportunity to ask the Company’s Auditor questions relevant to: a) the conduct of the audit; b) the preparation and content of the Independent Auditor’s Report; c) the accounting policies adopted by the Company in relation to the preparation of the financial statements; and d) the independence of the Auditor in relation to the conduct of the audit. The Chairman will also give the Auditor a reasonable opportunity to answer written questions submitted by Shareholders that are relevant to the content of the Independent Auditor’s Report or the conduct of the audit. All Shareholders present at the Meeting will have a reasonable opportunity to ask questions during the AGM. Shareholders who prefer to register questions in advance of the AGM are invited to do so by logging onto www.linkmarketservices.com.au and selecting ‘Voting’ and clicking ‘Ask a Question’, or otherwise emailing any questions to the Company Secretary at michael.austin@bio101.com To allow time to collate questions and prepare answers, please submit any questions by 5.00pm (Melbourne time) on Friday, 15 November 2024. Cryosite Ltd | 13a Ferndell Street, South Granville NSW 2142| t: +61 (2) 8865 2000 | e: corporate@cryosite.com | www.cryosite.com 1 Questions received in advance of the AGM by email will be collated and, during the AGM, the Chairman will seek to address as many of the more frequently raised topics as possible. However, there may not be sufficient time available at the AGM to address all topics raised. Please note that individual responses will not be sent to Shareholders. C. ITEMS FOR APPROVAL Resolution 1. Adoption of Remuneration Report To consider and, if thought fit, pass the following as a non–binding resolution: “That, for the purposes of section 250R(2) of the Corporations Act 2001 (Cth), the Company’s Remuneration Report for the financial year ended 30 June 2024, as set out in the Directors’ Report, is adopted.” Please note that, in accordance with section 250R(3) of the Corporations Act 2001 (Cth), the vote on this resolution is advisory only and does not bind the Directors or the Company. Voting Exclusion - Resolution 1 In accordance with section 250R of the Corporations Act, the Company will disregard any vote cast on this Resolution 1: a) in any capacity by, or on behalf of, a member of the Key Management Personnel (KMP) whose remuneration details are included in the Remuneration Report; or b) a Closely Related Party of such member, unless the vote is cast as a proxy for a person entitled to vote: c) and the proxy form specifies how the proxy is to vote; or d) the proxy is the Chair of the meeting and the appointment of the Chair as proxy: a. does not specify the way the proxy is to vote on the Resolution; and b. which expressly authorises the Chair to exercise the proxy even if the Resolution is connected directly or indirectly with the remuneration of a member of the KMP. Resolution 2. Election of Director – Mr. Mark Kerr To consider, and if thought fit, pass the following resolution as an ordinary resolution: "That Mr. Mark Kerr, a Director of Cryosite Limited, who retires in accordance with clause 59.2 of the Company’s Constitution, and being eligible and offering himself, is elected as a Director of Cryosite Limited." Resolution 3. Election of Director – Mr. Scott Thomas To consider, and if thought fit, pass the following resolution as an ordinary resolution: "That Mr. Scott Thomas, a Director of Cryosite Limited, who retires in accordance with clause 59.2 of the Company’s Constitution, and being eligible and offering himself, is elected as a Director of Cryosite Limited." Resolution 4. Election of Director – Mr. Andrew Kerr To consider, and if thought fit, pass the following resolution as an ordinary resolution: "That Mr. Andrew Kerr, a Director of Cryosite Limited, who retires in accordance with clause 59.2 of the Company’s Constitution, and being eligible and offering himself, is elected as a Director of Cryosite Limited." Cryosite Ltd | 13a Ferndell Street, South Granville NSW 2142| t: +61 (2) 8865 2000 | e: corporate@cryosite.com | www.cryosite.com 2 Resolution 5. Approval of Additional 10% Placement Capacity To consider and, if thought fit, pass the following as a special resolution: “That, for the purpose of Listing Rule 7.1A and for all other purposes, approval is given for the Company to have the additional capacity to issue Equity Securities totaling up to 10% of the issued capital of the Company (at the time of the issue), calculated in accordance with the formula prescribed in Listing Rule 7.1A.2 and on the terms and conditions set out in the Explanatory Memorandum.” Voting Exclusion - Resolution 5 The Company will disregard any votes cast in favour of this Resolution 5 by or on behalf of: a) any person who at the time approval pursuant to this Resolution 5 is sought the Company is proposing to make an issue of Equity Securities under rule 7.1A.2, any person who is expected to participate in, or who will obtain a material benefit as a result of, the proposed issue (except a benefit solely by reason of being a holder of ordinary securities in the Company); or b) an associate of that person or those persons. However, this does not apply to a vote cast in favour of this Resolution by: c) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with the directions given to the proxy or attorney to vote on the Resolution in that way; or d) the Chair of the meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the chair decides; or e) a Shareholder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met: a. the beneficiary provides written confirmation to the Shareholder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution, and b. the Shareholder votes on the Resolution in accordance with directions given by the beneficiary to the Shareholder to vote in that way. Resolution 6 – Change of Auditor To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution: “That, for the purposes of section 327B(1) of the Corporations Act and for all other purposes, Forvis Mazars Audit & Assurance Pty Ltd (ABN: 12 134 723 069) , having been nominated by a Shareholder and consented in writing to act as auditor of the Company, be appointed as auditor of the Company, effective immediately/as soon as ASIC consents to the resignation of the registered Auditor of the Company.” By order of the Board Michael Austin Company Secretary 21 October 2024 Cryosite Ltd | 13a Ferndell Street, South Granville NSW 2142| t: +61 (2) 8865 2000 | e: corporate@cryosite.com | www.cryosite.com 3 ALL RESOLUTIONS BY POLL In accordance with the Corporations Act and pursuant to clause 40.2.3 of the Company’s Constitution, the Chairman will call a poll for each of the Resolutions proposed at the AGM. ENTITLEMENT TO ATTEND AND VOTE In accordance with regulation 7.11.37 of the Corporations Regulations 2001 (Cth), the Board has determined that persons who are registered holders of Shares of the Company as at 7.00pm (Melbourne time) on Wednesday, 20 November 2024 will be entitled to attend and vote at the AGM as Shareholders. If more than one joint holder of Shares is present at the AGM (whether personally or by proxy or by attorney or by representative) and tenders a vote, only the vote of the joint holder whose name appears first in the Company’s share register will be counted. Appointment of Proxy If you are a Shareholder entitled to attend and vote at the AGM, you may appoint an individual or a body corporate as a proxy. If a body corporate is appointed as a proxy, that body corporate must ensure that it appoints a corporate representative in accordance with section 250D of the Corporations Act to exercise its powers as proxy at the AGM. A proxy need not be a shareholder of the Company. A Shareholder may appoint up to two proxies to attend and vote at the AGM on that Shareholder’s behalf and the appointment may specify the proportion or number of votes each proxy may exercise at the AGM. If the Shareholder does not specify the proportion or number of votes to be exercised, each proxy may exercise half of the Shareholder’s votes. A proxy may vote or abstain as he or she chooses except where the appointment of the proxy directs the way the proxy is to vote on a particular resolution. To be effective, the Proxy Form (and, if the appointment is signed or authenticated by the Shareholder’s attorney, the authority under which it was signed or authenticated or a certified copy of the authority) must be received at the Share Registry of the Company no later than 11.00am (Melbourne time) on Wednesday, 20 November 2024 (being 48 hours before the AGM). Proxies must be received before that time by one of the following methods: Online (preferred): www.linkmarketservices.com.au BY MAIL: Cryosite Limited C/- Link Market Services Limited Locked Bag A14 Sydney South NSW 1235 Australia BY FAX: 02 9287 0309 (within Australia) +61 2 9287 0309 (from outside Australia) BY HAND: Link Market Services Limited* Level 12 680 George Street Sydney NSW 2000 *During business hours Monday to Friday (9:00am to 5:00pm). If you have any enquiries, please contact our Share Registry at 1300 554 474 or +61 1300 554 474 if you are calling from overseas. To be valid, a proxy form must be received by the Company in the manner stipulated above. The Company reserves the right to declare invalid any proxy not received in this manner. Cryosite Ltd | 13a Ferndell Street, South Granville NSW 2142| t: +61 (2) 8865 2000 | e: corporate@cryosite.com | www.cryosite.com 4 Power of Attorney A Proxy Form and the original power of attorney (if any) under which the Proxy Form is signed (or a certified copy of that power of attorney or other authority) must be received by the Company no later than 11.00am (Melbourne time) on Wednesday, 20 November 2024, being 48 hours before the AGM. Corporate Representatives A body corporate which is a Shareholder, or which has been appointed as a proxy, is entitled to appoint any person to act as its representative at the AGM. The appointment of the representative must comply with the requirements under section 250D of the Corporations Act. The representative should bring to the AGM a properly executed letter or other document confirming its authority to act as the body corporate’s representative. A “Certificate of Appointment of Corporate Representative” form may be obtained from the Company’s share registry or online at www.linkmarketservices.com.au. IMPORTANT: If you appoint the Chairman of the Meeting as your proxy, or the Chairman becomes your proxy by default, and you do not direct your proxy how to vote on Resolution 1 then by submitting the proxy form you will be expressly authorising the Chairman to exercise your proxy on the relevant resolution, even though the resolutions are connected, directly or indirectly, with the remuneration of the KMP. SHAREHOLDER QUESTIONS – SUBMITTED PRIOR TO THE MEETING Shareholders who are unable to attend the Meeting or who may prefer to register questions in advance of the Meeting are invited to do so by logging onto www.linkmarketservices.com.au, selecting ‘Voting’ then clicking ‘Ask a Question’. This includes any questions for the Chairman or the Auditor. To allow time to collate questions and prepare answers, please submit any questions by 5:00pm (Melbourne time) on Friday, 15 November 2024 (being no later than the fifth business day before the AGM is held). Questions will be collated and, during the AGM, the Chairman will seek to address as many of the more frequently raised topics as possible. However, there may not be sufficient time available at the AGM to address all topics raised. Please note that individual responses will not be sent to Shareholders. CONDUCT OF MEETING Cryosite is committed to ensuring that its shareholder meetings are conducted in a manner which provides those shareholders (or their proxy holders) who attend the meeting with the opportunity to participate in the business of the meeting in an orderly fashion and to ask questions about and comment on matters relevant to the business of the meeting or about the Company generally. Cryosite will not allow conduct at any shareholder meeting which is discourteous to those who are present at the meeting, or which in any way disrupts or interferes with the proper conduct of the meeting. The Chairman of the meeting will exercise his powers as the Chairman to ensure that the meeting is conducted in an orderly and timely fashion, in the interests of all attending shareholders. ENCLOSURES Enclosed are the following documents: • Proxy Form to be completed if you would like to be represented at the AGM by a proxy, noting that Shareholders are encouraged to use the online voting facility that can be accessed on Cryosite’s Share Registry’s website at www.linkmarketservices.com.au to ensure the timely and cost-effective receipt of your proxy; and • a reply-paid envelope for you to return the Proxy Form. Cryosite Ltd | 13a Ferndell Street, South Granville NSW 2142| t: +61 (2) 8865 2000 | e: corporate@cryosite.com | www.cryosite.com 5 EXPLANATORY MEMORANDUM This Explanatory Memorandum has been prepared to provide Shareholders with information that is reasonably required by Shareholders to decide how to vote upon the resolutions and in relation to the business to be conducted at the Company’s AGM to be held on Friday, 22 November 2024. Subject to the abstentions noted below, the Directors unanimously recommend Shareholders vote in favour of all Resolutions. The Chairman of the Meeting intends to vote all available undirected proxies in favour of each Resolution. Resolution 1, relating to the Remuneration Report, is advisory only and does not bind the Directors or the Company. Resolutions 2,3,4 and 6, are ordinary resolutions, which require a simple majority of votes cast by Shareholders present and entitled to vote on the Resolutions. Resolution 5 is a special resolution and will require 75% votes cast by Shareholders present and entitled to vote on the Resolutions to pass. Cryosite Ltd | 13a Ferndell Street, South Granville NSW 2142| t: +61 (2) 8865 2000 | e: corporate@cryosite.com | www.cryosite.com 6 Resolution 1: Adoption of Remuneration Report Section 250R(2) of the Corporations Act requires that the Remuneration Report of the Company be put to the vote of Shareholders for adoption by way of a non–binding vote. Broadly, the Remuneration Report details the remuneration policy for the Company which: • discusses the Company’s policy in relation to remuneration of the KMP; • discusses the relationship between the Board’s remuneration policy and Company’s performance; • details any performance conditions attached to KMP remuneration; and • sets out remuneration details for each KMP. Shareholders can view the full Remuneration Report in the Annual Report which is available on the Company’s website at https://investors.cryosite.com/investors/?page=announcements. Following consideration of the Remuneration Report, the Chair of the Meeting will give Shareholders a reasonable opportunity to ask questions about, or make comments on, the Remuneration Report. A resolution that the Remuneration Report be adopted will then be put to the vote. The vote on Resolution 1 is advisory only and does not bind the Directors of the Company. However, the Board will take the outcome of the vote into account in setting the remuneration policy for future years. Voting exclusion statement In accordance with section 250R of the Corporations Act, a vote on Resolution 1 must not be cast (in any capacity) by, or on behalf of, the following persons: a. a member of the Key Management Personnel (KMP) whose remuneration details are included in the 2024 Remuneration Report; or b. a closely related party of such member of the KMP (including close family members and companies the KMP controls). However, a person described above may cast a vote on Resolution 1 as a proxy if the vote is not cast on behalf of a person described above and either: a. the proxy appointment is in writing and specifies the way the proxy is to vote (e.g., for, against, abstain) on the resolution; or b. the vote is cast by the Chairman of the Meeting and the appointment of the Chairman as proxy: i. does not specify the way the proxy is to vote on the resolution; and ii. expressly authorises the Chairman to exercise the proxy even if the resolution is connected directly or indirectly with the remuneration of a member of the KMP. For the purpose of the voting exclusion above, “key management personnel” and “closely related party” have the same meaning as set out in the Corporations Act. In accordance with section 250BD of the Corporations Act 2001 (Cth), a vote must not be cast on Resolution 1 as a proxy by a member of the KMP at the date of the AGM, or a closely related party of those persons, unless it is cast as proxy for a person entitled to vote in accordance with their directions. This restriction on voting undirected proxies does not apply to the Chairman of the Meeting where the proxy appointment expressly authorises the Chairman of the Meeting to exercise undirected proxies even if the resolution is connected, directly or indirectly, with the remuneration of the KMP. Directors’ Recommendation: Noting that each Director has a personal interest in their own remuneration from the Company as set out in the Remuneration Report, the Directors unanimously recommends that Shareholders vote in favour of adopting the Remuneration Report. Cryosite Ltd | 13a Ferndell Street, South Granville NSW 2142| t: +61 (2) 8865 2000 | e: corporate@cryosite.com | www.cryosite.com 7 Resolution 2: Election of Director – Mr. Mark Kerr The Company’s Constitution provides that any Director appointed in addition to the existing Directors will hold office until the next following annual general meeting and is then eligible for election. ASX Listing Rule 14.4 also provides that each additional director appointed during the year is to hold office until the next annual general meeting and is then eligible for election as a Director of the Company. Mark Kerr was appointed as an additional Director of the Company on 8, December 2023 and has since served as a Director of the Company. Under this Resolution, Mark Kerr seeks election as a Director of the Company at this AGM. Biography Mark is a highly experienced professional with a specialisation in Reputation Management and Public Relations. His expertise extends to finance, marketing, property, the stock market, political, and issues management. He has a legal background with a LL.B. degree from the University of Melbourne and experience as a solicitor. Previously, Mark was the chairman and managing director of Hawthorn Resources Limited, and chairman of WCM Global Long Short Limited and Think Childcare Limited. Currently, Mark is the non-executive director of Nido Education Limited, which listed on the ASX in 2023. Mark also serves as a director of Berkeley Consultants, focusing on public relations, investor relations and reputation management. Directors’ Recommendation: On the basis of Mr. Mark Kerr’s skills, qualifications and experience and his contribution to the Board’s activities, the Directors, with Mr. Mark Kerr abstaining, unanimously support the election of Mr. Mark Kerr as a Director. Cryosite Ltd | 13a Ferndell Street, South Granville NSW 2142| t: +61 (2) 8865 2000 | e: corporate@cryosite.com | www.cryosite.com 8 Resolution 3: Election of Director – Mr. Scott Thomas The Company’s Constitution provides that any Director appointed in addition to the existing Directors will hold office until the next following annual general meeting and is then eligible for election. ASX Listing Rule 14.4 also provides that each additional director appointed during the year is to hold office until the next annual general meeting and is then eligible for election as a Director of the Company. Scott Thomas was appointed as an additional Director of the Company on 9, May 2024 and has since served as a Director of the Company. Under this Resolution, Scott Thomas seeks election as a Director of the Company at this AGM. Biography Scott has strong experience in the financial services profession both in Australia and the United Kingdom having held senior roles at ANZ and Vanguard Investments. Scott holds a Diploma of Financial Strategy (Oxford University), a Master of Applied Finance (Macquarie University) and a Bachelor of Commerce (The University of Melbourne). Directors’ Recommendation: On the basis of Mr. Scott Thomas’s skills, qualifications and experience and his contribution to the Board’s activities, the Directors, with Mr. Scott Thomas abstaining, unanimously support the election of Mr. Scott Thomas as a Director. Cryosite Ltd | 13a Ferndell Street, South Granville NSW 2142| t: +61 (2) 8865 2000 | e: corporate@cryosite.com | www.cryosite.com 9 Resolution 4: Election of Director – Mr. Andrew Kerr The Company’s Constitution provides that any Director appointed in addition to the existing Directors will hold office until the next following annual general meeting and is then eligible for election. ASX Listing Rule 14.4 also provides that each additional director appointed during the year is to hold office until the next annual general meeting and is then eligible for election as a Director of the Company. Andrew Kerr was appointed as an additional Director of the Company on 22, February 2024 and has since served as a Director of the Company. Under this Resolution, Andrew Kerr seeks election as a Director of the Company at this AGM. Biography Andrew is an experienced financial services professional in both the Australian and international markets. Andrew is a qualified Certified Practising Accountant (CPA) and a graduate of the Australian Institute of Company Directors (GAICD) course. Through his roles at the Bank of America Merrill Lynch and Macquarie Bank, Andrew has obtained strong sustainability and ESG credentials which will greatly complement the Board. Directors’ Recommendation: On the basis of Mr. Andrew Kerr’s skills, qualifications and experience and his contribution to the Board’s activities, the Directors, with Mr. Andrew Kerr abstaining, unanimously support the election of Mr. Andrew Kerr as a Director. Cryosite Ltd | 13a Ferndell Street, South Granville NSW 2142| t: +61 (2) 8865 2000 | e: corporate@cryosite.com | www.cryosite.com 10 Resolution 5. Approval of Additional 10% Placement Capacity 5.1. General Listing Rule 7.1A provides that an Eligible Entity may seek shareholder approval to allow it to issue equity securities up to the 10% Placement Capacity. Approval under Listing Rule 7.1A is an increase in the Company’s entitlement or capacity to issue a further 10% of its issued capital. There is no guarantee that the Company will issue any Shares under this 10% Placement Capacity. The Company is an Eligible Entity (as described below). If Shareholders approve Resolution 5, the number of Equity Securities the Company may issue under the 10% Placement Capacity will be determined in accordance with the formula prescribed in Listing Rule 7.1A.2 (as set out below). The effect of Resolution 5 will be to allow the Company to issue Equity Securities up to 10% of the Company’s fully paid ordinary securities on issue under the 10% Placement Capacity during the period up to 12 months after the Meeting (refer to 10% Placement Capacity Period defined below), without prior Shareholder approval and without using the Company’s 15% Placement Capacity granted under Listing Rule 7.1. If Resolution 5 is not passed, the Company will not be able to access the 10% Placement Capacity and will remain subject to the 15% Placement Capacity set out in Listing Rule 7.1. Resolution 5 is a special resolution. Accordingly, at least 75% of votes cast by Shareholders present and eligible to vote at the Meeting must be in favour of Resolution 5 for it to be passed. 5.2. Listing Rule 7.1A Listing Rule 7.1A enables an Eligible Entity to seek Shareholder approval at its annual general meeting to issue Equity Securities in addition to those available to be issued under the Eligible Entity’s 15% Placement Capacity. An ‘Eligible Entity’ is one that, as at the date of the relevant annual general meeting: (a) is not included in the A&P/ASX 300 Index; and (b) has a maximum market capitalisation (excluding restricted securities and securities quoted on a deferred settlement basis) of $300m. The Company is an Eligible Entity as it is not included in the A&P/ASX 300 Index and at the date of this Notice has a current market capitalisation of approximately $42.95m based on a Share price of $0.880 as at 4 October 2024. The Equity Securities must be in the same class as an existing class of quoted Equity Securities. The Company currently has one class of quoted Equity Securities, being fully paid ordinary shares. The exact number of Equity Securities that the Company may issue under an approval under Listing Rule 7.1A will be calculated according to the following formula: (A x D) – E Where: A is the number of Shares on issue 12 months before the date of issue or agreement: • plus the number of fully paid ordinary securities issued in the relevant period under an exception in Listing Rule 7.2 other than exception 9, 16 or 17, • plus the number of fully paid ordinary securities issued in the relevant period on the conversion of convertible securities within Listing Rule 7.2 exception 9 where: • the convertible securities were issued or agreed to be issued before the commencement of the Cryosite Ltd | 13a Ferndell Street, South Granville NSW 2142| t: +61 (2) 8865 2000 | e: corporate@cryosite.com | www.cryosite.com 11 12 month period; or • the issue of, or agreement to issue, the convertible securities was approved, or taken under these rules to have been approved, under Listing Rule 7.1 or Listing Rule 7.4, • plus the number of fully paid ordinary securities issued in the relevant period under an agreement to issue securities within Listing Rule 7.2 exception 16 where: • the agreement was entered into before the commencement of the 12 month period; or • the agreement or issue was approved, or taken under these rules to have been approved, under Listing Rule 7.1 or Listing Rule 7.4, • plus the number of any other fully paid ordinary securities issued in the 12 month period with approval under Listing Rule 7.1 or Listing Rule 7.4, • plus the number of partly paid ordinary securities that becam